Business Model

LUPI’s business model is built on three areas ensuring a great flexibility in the production planning and capacity utilization and guaranteeing an optimum level of plant occupancy, effective costs management and high competitiveness.

LUPI Patents

CUSTOM MANUFACTURING
LUPI offers to its customers a complete range of development and production services for cGMP advanced intermediates and APIs from route screening to process development and optimization, industrialization and large scale commercial production.

GENERIC APIs
LUPI has a long tradition as manufacturer of APIs for the generics market. Thanks to both its knowledge and expertise in process chemistry, IPR and regulatory affairs and its professional team, LUPI adds to its pipeline an average of 2-3 molecules per year.

H. LUNDBECK A/S cGMP INTERMEDIATES AND APIs
LUPI is actively involved in H. Lundbeck A/S supply chain providing apis and intermediates both for clinical trials and mature finished products.

Page last modified 29 June 2012

Lundbeck Pharmaceuticals Italy S.p.A. Quarta Strada 2 | 35129 | Padova | Italy
Phone +39 049 869 9311 | Fax +39 049 807 7146

C.F./P.I. 00208120287 - Direzione e coordinamento H. Lundbeck.A/S

You are about to leave Lundbeck Pharmaceuticals Italy homepage

Choose region and then country

Other Lundbeck sites

Global contacts

Business Model

LUPI’s business model is built on three areas ensuring a great flexibility in the production planning and capacity utilization and guaranteeing an optimum level of plant occupancy, effective costs management and high competitiveness.